A multistate clinical trial that included researchers from the University of Tennessee Health Science Center and the Memphis Veterans Affairs Medical Center has been selected for one of the 2020 Top 10 Clinical Research Achievement Awards by the Clinical Research Forum. The SPRINT MIND (Systolic Blood Pressure Intervention Trial Memory and Cognition IN Decreased Hypertension)… Read More
Karen C. Johnson, MD, MPH, College of Medicine Endowed Professor in Women’s Health and a principal investigator for several groundbreaking national and international public health research studies, is the new chair of the Department of Preventive Medicine at the University of Tennessee Health Science Center. A tenured professor in the Departments of Preventive Medicine and… Read More
A researcher from the University of Tennessee Health Science Center is among principal investigators on a six-year nationwide diabetes prevention clinical trial that released findings today at the American Diabetes Association’s 79th Scientific Sessions in San Francisco. The Vitamin D and Type 2 diabetes (D2d) study found that vitamin D supplementation does not significantly reduce… Read More
Researchers at the University of Tennessee Health Science Center (UTHSC) were part of the federally-funded Women’s Health Initiative (WHI) multisite clinical trial, which released study findings last week showing that postmenopausal women with no previous history of breast cancer reportedly had a 21 percent lower risk of death from breast cancer if they followed a… Read More
Researchers at the University of Tennessee Health Science Center and the Memphis Veterans Affairs (VA) Medical Center were part of the SPRINT MIND (Systolic Blood Pressure Intervention Trial Memory and Cognition IN Decreased Hypertension) multisite clinical trial, which today released data showing aggressively lowering blood pressure reduces the risk of mild cognitive impairment (MCI) and… Read More
Memphis, Tenn. (June 26, 2013) – Can taking calcium and vitamin D help prevent bone fractures among women taking postmenopausal hormone therapy? That’s the question that researchers and more than 60,000 women have tried to answer through a Women’s Health Initiative study. Over more than 19 years, postmenopausal participants aged 50 to 79 years enrolled… Read More
